Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.

Peter A. McCullough,Huiman X. Barnhart,Jula K. Inrig,Donal N. Reddan,Shelly Sapp,Uptal D. Patel,Ajay K. Singh,Lynda A. Szczech,Robert M. Califf

Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.

2013

Peter A. McCullough
Huiman X. Barnhart
Jula K. Inrig
Donal N. Reddan
Shelly Sapp
Uptal D. Patel
Ajay K. Singh
Lynda A. Szczech
Robert M. Califf

Background: Recombinant erythropoietin has become a routine component of care of patients with chronic kidney disease reducing the need for blood transfusions but

Keywords:

Erythropoietin
Epoetin alfa
Epidemiology
Anemia
Kidney disease
Intensive care medicine
Toxicity
Medicine
Diabetes mellitus
cardiovascular toxicity
in patient
recombinant erythropoietin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations